Unity Biotechnology, Inc. (UBX) Misses Q1 EPS by 59c
Tweet
Share
E-mailGet Alerts UBX Hot Sheet
Join SI Premium – FREE
Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Credo Technology shares rise on analyst support and conference comments
- Rubico to shift from semi-annual to quarterly financial reporting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
